U.S. flag

An official website of the United States government

NM_004183.4(BEST1):c.240C>G (p.Phe80Leu) AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 30, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001959058.5

Allele description

NM_004183.4(BEST1):c.240C>G (p.Phe80Leu)

Gene:
BEST1:bestrophin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q12.3
Genomic location:
Preferred name:
NM_004183.4(BEST1):c.240C>G (p.Phe80Leu)
HGVS:
  • NC_000011.10:g.61955194C>G
  • NG_009033.1:g.10311C>G
  • NM_001139443.2:c.60C>G
  • NM_001300786.2:c.60C>G
  • NM_001300787.2:c.60C>G
  • NM_001363592.1:c.240C>G
  • NM_004183.4:c.240C>GMANE SELECT
  • NP_001132915.1:p.Phe20Leu
  • NP_001287715.1:p.Phe20Leu
  • NP_001287716.1:p.Phe20Leu
  • NP_001350521.1:p.Phe80Leu
  • NP_004174.1:p.Phe80Leu
  • NC_000011.9:g.61722666C>G
  • NR_134580.2:n.353C>G
Protein change:
F20L
Links:
dbSNP: rs281865221
NCBI 1000 Genomes Browser:
rs281865221
Molecular consequence:
  • NM_001139443.2:c.60C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300786.2:c.60C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300787.2:c.60C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363592.1:c.240C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004183.4:c.240C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_134580.2:n.353C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002246570Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Sep 30, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Disease-associated missense mutations in bestrophin-1 affect cellular trafficking and anion conductance.

Milenkovic VM, Röhrl E, Weber BH, Strauss O.

J Cell Sci. 2011 Sep 1;124(Pt 17):2988-96. doi: 10.1242/jcs.085878.

PubMed [citation]
PMID:
21878505

Molecular diagnostic testing by eyeGENE: analysis of patients with hereditary retinal dystrophy phenotypes involving central vision loss.

Alapati A, Goetz K, Suk J, Navani M, Al-Tarouti A, Jayasundera T, Tumminia SJ, Lee P, Ayyagari R.

Invest Ophthalmol Vis Sci. 2014 Jul 31;55(9):5510-21. doi: 10.1167/iovs.14-14359.

PubMed [citation]
PMID:
25082885
PMCID:
PMC4152151
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV002246570.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 80 of the BEST1 protein (p.Phe80Leu). This variant is not present in population databases (gnomAD no frequency). A different variant (c.240C>A) giving rise to the same protein effect has been determined to be pathogenic (PMID: 21878505, 25082885, 26201355). This suggests that this variant is also likely to be causative of disease. ClinVar contains an entry for this variant (Variation ID: 1459557). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function. This variant disrupts the p.Phe80 amino acid residue in BEST1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21878505, 25082885, 26201355, 28806213). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024